General
Novavax COVID-19 vaccine 89 per cent effective, according to early UK trials
Novavax, one of three companies the Federal Government has struck a deal with to distribute COVID-19 vaccines in Australia, said its offering appears 89 per cent effective based on early findings from a British study.
Key points:
- A trial of 15,000 people in Britain is still underway, but an interim analysis found 62 participants so far have been diagnosed with COVID-19
- Only six of the unwell participants got the vaccine and the rest received dummy shots
- More than half of the participants who became infected in the UK trial had the mutated version of the virus
Findings based on the trial also found that the vaccine seems to work — although not as well — against new mutated versions of the virus circulating in the UK and South Africa.
While…
Continue Reading